Clinical Trial

Overlooked Barrier To Discontinuing Bont-A Therapy

Completed
View on ClinicalTrials.gov →
Summary
This study aims to evaluate patient adherence to botulinum toxin (BoNT-A) treatment and identify the factors contributing to its discontinuation. This retrospective cohort study analyzed the medical records of patients who received at least one botulinum toxin treatment for post-stroke spasticity (PSS) from 2012 to 2024. Eighty-one enrolled patients responded to structured questions about their reasons for not consistently continuing BoNT-A treatment.
Trial Details
NCT Number NCT07422428
Lead Sponsor Suleyman Demirel University
Conditions Post Stroke Spastic Hemiplegia
Enrollment 81 participants
Start Date 2024-09-23
Primary Completion 2025-02-10 (estimated)
Study Completion 2025-04-05 (estimated)
Updated on ClinicalTrials.gov 2026-02-20